亞太藥業(002370.SZ)股東鍾婉珍補充質押400萬股
格隆匯8月23日丨亞太藥業(002370.SZ)公佈,2019年8月23日,公司接到股東鍾婉珍的通知,鍾婉珍將其所持有的公司股份400萬股質押給銀河金匯證券資產管理有限公司,作為其為公司控股股東浙江亞太集團有限公司(“亞太集團”)於2018年11月29日所做質押式回購進行的補充質押。
截至本公告披露日,亞太集團持有公司股份約1.08億股,佔公司總股本的20.15%,亞太集團全資子公司紹興柯橋亞太房地產有限公司持有公司股份4066.2萬股,佔公司總股本的7.58%,實際控制人陳堯根公司持有公司股份2714.0218萬股,佔公司總股本的5.06%,實際控制人陳堯根公司的配偶鍾婉珍持有公司股份2110.1892萬股,佔公司總股本的3.93%,目前,控股股東亞太集團、實際控制人陳堯根公司及其一致行動人累計質押其持有的公司股份為約1.70億股,佔其所持公司股份的86.09%,佔公司總股本的31.61%。
.
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.